Westbrook, Maine, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Synergy CHC Corp (OTCQB: SNYR), a consumer health care & beauty company, announces the appointment of Gale Bensussen to its Board of Directors. Mr. Bensussen’s appointment expands the Board to 4 directors, 3 of whom are independent.
“As Synergy continues to grow with an eye towards an uplisting to a major exchange sometime in 2018, it’s important for the company to grow its corporate governance through independent directors with industry specific experience. Gale’s experience and track record in our industry is second to none. We are very fortunate to add an independent director of Gale’s caliber to help steer our company with the goal of creating exponential shareholder value. In the coming days and weeks, Synergy will be announcing further independent directors and will be adding key management team members, which will help support our corporate initiatives to grow organically and by further acquisition. We are excited to welcome Gale to the board.” said Jack Ross, Chairman and CEO of Synergy.
Gale Bensussen is the President and Chief Executive Officer of Kingdomway USA a wholly owned subsidiary of Kingdomway Group Companies which is listed on the Shenzhen Stock Exchange. Mr. Bensussen led Kingdomway’s acquisition of Doctor’s Best one of the internet’s leading nutritional brands, Vit-Best Nutrition a contract manufacturer of dietary supplements, as well as, investments in leading sports nutrition brands including ProSupps and Labrada. He is also an advisor to North Castle Partners a private equity firm focused on Healthy Living, Aging and Sustainability.
Previously Bensussen was a founder and president of Leiner Health Products which became one of the world’s largest manufacturers of nutritional supplements and over-the-counter drugs. During his 32 years with Leiner he participated in a leveraged buyout, public offering and managed the transition to private equity ownership and a series of recapitalizations. At Leiner he led more than a half dozen acquisitions and numerous joint ventures. Internationally, he negotiated and was responsible for the building the first American owned dietary supplement manufacturing and packaging facility in China. A joint venture with one of India’s largest pharmaceutical research companies resulted in first approvals in the United States for several prescription drugs t for over-the-counter use and sales.